Chemotherapy of metastatic malignant melanoma. Experience with 73 patients.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002699:Chlorambucil / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D005134:Eye Neoplasms / Q000188:drug therapy*; D005260:Female; D005467:Floxuridine / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007065:Idoxuridine / Q000627:therapeutic use; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use; D014846:Vulvar Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D009607:Nitrosourea Compounds; D005467:Floxuridine; D003561:Cytarabine; D002699:Chlorambucil; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D007065:Idoxuridine; D008558:Melphalan; D003078:Colchicine; D006918:Hydroxyurea